5-methoxytryptophan alleviates liver fibrosis by modulating FOXO3a/miR-21/ATG5 signaling pathway mediated autophagy-Reference-Cited by-同舟云学术

5-methoxytryptophan alleviates liver fibrosis by modulating FOXO3a/miR-21/ATG5 signaling pathway mediated autophagy

Published:2021-03-18 Issue:7 Volume:20 Page:676-688
ISSN:1538-4101
Container-title:Cell Cycle
language:en
Short-container-title:Cell Cycle

Author:

Tong Ming¹²,Zheng Qing³,Liu Meng¹,Chen Liang¹,Lin Yi-He¹,Tang Shi–Gang¹,Zhu Yi-Min²⁴^ORCID

Affiliation:

1. Department of Infectious Diseases, Hunan Provincial People‘s Hospital (The First Affiliated Hospital of Hunan Normal University), Changsha Hunan Province, P.R. China

2. College of Life Sciences, Hunan Normal University, Changsha Hunan Province (The First Affiliated Hospital of Hunan Normal University),P.R. China

3. Department of Geriatrics, Hunan Provincial People‘s Hospital(The First Affiliated Hospital of Hunan Normal University), Changsha Hunan Province,P.R. China

4. Institute of Emergency Medicine, Hunan Provincial Key Laboratory of Emergency and Critical Care Metabonomics, Hunan Provincial People‘s Hospital (The First Affiliated Hospital of Hunan Normal University), Changsha Hunan Province, P.R. China

Funder

Hunan Natural Science Foundation of Youth Project

Publisher

Informa UK Limited

Subject

Cell Biology,Developmental Biology,Molecular Biology

Link

https://www.tandfonline.com/doi/pdf/10.1080/15384101.2021.1897241

Reference43 articles.

1. Liver fibrosis – from bench to bedside

2. Pathogenesis of Liver Fibrosis

3. Evolving therapies for liver fibrosis